Economy
Producer Price Index
U.S. Producer price index continued to rise in February, but on the lower pace.
|
Housing Starts
The construction of new homes, as well as the issuance of new building permits declined in February, signaling slowdown in economic growth and decrease in business profitability.
|
![Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/durable_goods/Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg "Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons")
Durable Goods Orders
Durable Goods orders continued to grow, as bookings outgrow production.
|
|
![pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Cytodyn inc
In the fiscal third quarter of 2021 Cytodyn Inc lost money of $-0.08 per share compared to $-0.08 a year ago and increased losses from $-0.06 per share from the previous quarter.
Cytodyn Inc reported operating shortfall of $-30.785 millions, in the fiscal third quarter of 2021, a deterioration from the operating shortfall of $-22.074684 millions, realized in third quarter of 2020
CYDY stock quotes, charts, profile
Growth Rates, Profitability, PE
.jpg "Marijuana_leaf_at_Veer_Guest_House,_Manali_(164703748)")
Lexaria Bioscience Corp
Lexaria Bioscience Corp announced earnings per share of $0.09 and Sales of $0.30 millions in the second quarter of 2021, Company's turn a round per share, versus $-0.01 eps, earned in the same quarter a year ago, although Lexaria Bioscience Corp saw its Sales rise by 79.61% in the same period.
In contrast to the first quarter Sales Tumbled by -35.2% from $0.30 millions and EPS turn positive from $-0.24 per share.
|
![Inside_a_computer_By_nrkbeta_(originally_posted_to_Flickr_as_Maskinvare)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common](../news/img/semiconductors/Inside_a_computer_By_nrkbeta_(originally_posted_to_Flickr_as_Maskinvare)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common.jpg "Inside_a_computer_By_nrkbeta_(originally_posted_to_Flickr_as_Maskinvare)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common")
Surge Components Inc
Due to strong revenue growth company turned into profitability, Sales grew by 20.14% to $8.16 millions, earnings per share were at $0.05, compared to $-0.05 in the same quarter a year ago.
Sequentially eps dropped by -71.57% from $0.18 per share and Sales fell by -15.16% from $9.61 millions.
|
|
Recently Reported Results |
|
Cannabics Pharmaceuticals Inc
In the second quarter of 2021 Cannabics Pharmaceuticals Inc reached break-even of $0.00 per share compared to $-0.00 a year ago and from $-0.01 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.
CNBK stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Citi Trends inc
Company displayed pleasant results in the fourth quarter of 2020. Sales were at $251.92 millions higher by 19.39% year on year and improved by 26.53 % quarter on quarter, while earnings per share more than doubled by 114.78 % to $1.80, sequentially eps more than doubled by 169.28 %.
In the fiscal year 2020, Citi Trends Inc reported Sales of $783.29 millions and net income of $23.98 millions.
Eps soared by 64.54 % to $2.32 per share from $1.41 in the previous fiscal year, while Sales increased by 0.18 % from $781.93 millions a year ago.
CTRN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Teardroppers Inc
Teardroppers Inc announced earnings per share of $-0.00 and Sales of $0.02 millions in the most recent fiscal period, Company's reached break-even per share, versus $-0.00 eps, earned in the same quarter a year ago, although Teardroppers Inc saw its Sales rise by 50.85% in the same period.
In contrast to the third quarter Sales increased by 3.89 % from $0.02 millions and from $0.00 per share.
In the fiscal year 2020, Citi Trends Inc reported Sales of $783.29 millions and net income of $23.98 millions.
Eps soared by 64.54 % to $2.32 per share from $1.41 in the previous fiscal year, while Sales increased by 0.18 % from $781.93 millions a year ago.
TRDP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Mikroprozessor_By_Elmar_Ersch_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/semiconductors/Mikroprozessor_By_Elmar_Ersch_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Mikroprozessor_By_Elmar_Ersch_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Genethera Inc
In the fiscal fourth quarter of 2020 Genethera Inc reached break-even of $-0.00 per share compared to $-0.01 a year ago and from $-0.01 per share from the previous quarter.
Genethera Inc reported operating loss of $-0.132123 millions, in the fiscal fourth quarter of 2020, an improvement from the operating shortfall of $-0.239101 millions, realized in fourth quarter of 2019
Genethera Inc reported net loss of $-0.77 millions and Sales of $0.00 millions for the fiscal year 2020.
Net loss per share has widen to $-0.04 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
GTHR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
High Sierra Technologies Inc
In the fourth quarter of 2020 High Sierra Technologies Inc increased losses of $-0.01 per share compared to $-0.00 a year ago and from $0.00 per share from the previous quarter.
High Sierra Technologies Inc reported operating deficit of $-0.187955 millions, in the fourth quarter of 2020, a deterioration from the operating surplus of $0.012858 millions, realized in fourth quarter of 2019
Genethera Inc reported net loss of $-0.77 millions and Sales of $0.00 millions for the fiscal year 2020.
Net loss per share has widen to $-0.04 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
GLFO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Khozam_By_BandarSar_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/realestate/Khozam_By_BandarSar_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Khozam_By_BandarSar_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Eaco Corp
Eaco Corp realized a deterioration in earnings per share by -47.17% to $0.28 and Sales decrease by -1.9% to $55.75 millions in the most recent fiscal period, year on year.
From the preceding quarter, eps soared from $0.17 per share and Sales increased by 4.4 % from $53.40 millions.
EACO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
Recently Reported Results |
|
Cytodyn inc
In the most recent fiscal period Cytodyn Inc lost money of $-0.08 per share compared to $-0.08 a year ago and increased losses from $-0.06 per share from the previous quarter.
Cytodyn Inc reported operating loss of $-30.785 millions, in the most recent fiscal period, a deterioration from the operating shortfall of $-22.074684 millions, realized in third quarter of 2020
CYDY stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Housing Starts
The construction of new homes, as well as the issuance of new building permits declined in February, signaling slowdown in economic growth and decrease in business profitability.
|
Enertopia Corp
Enertopia Corp announced operating loss of $-0.327792 millions, in the fiscal period ending Feb 28 2021, a change from the operating shortfall of $-0.055649 millions, recorded in the same quarter a year ago.
ENRT stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Nanovation Microtech Inc
In the fiscal second quarter of 2021 Nanovation Microtech Inc loss increased of $-0.12 per share compared to $0.00 a year ago and improved from $-0.38 per share from the previous quarter.
Nanovation Microtech Inc reported operating shortfall of $-0.00423 millions, in the fiscal second quarter of 2021, an improvement from the operating shortfall of $-0.055649 millions, realized in second quarter of 2020
NANN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Cannabics Pharmaceuticals Inc
In the second quarter of 2021 Cannabics Pharmaceuticals Inc reached break-even of $0.00 per share compared to $-0.00 a year ago and from $-0.01 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.
CNBK stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Durable Goods Orders
Durable Goods orders continued to grow, as bookings outgrow production.
|
Gross Domestic Product
The Gross domestic product, the measurement of the nations output, improved in the fourth-quarter, as private domestic investments and foreign demand for American products pick up.
|
Industrial production
Fed reported declining U.S. Industrial production in February, as the demand for industrial goods softens.
|
![Shopping_Malll_Antwerpen_By_FaceMePLS_from_The_Hague_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common](../news/img/shopping/Shopping_Malll_Antwerpen_By_FaceMePLS_from_The_Hague_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common.jpg "Shopping_Malll_Antwerpen_By_FaceMePLS_from_The_Hague_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common")
Citi Trends inc
Company displayed pleasant results in the most recent fiscal period. Sales were at $251.92 millions higher by 19.39% year on year and improved by 26.53 % quarter on quarter, while earnings per share more than doubled by 114.78 % to $1.80, sequentially eps more than doubled by 169.28 %.
In the fiscal year 2020, Citi Trends Inc reported Sales of $783.29 millions and net income of $23.98 millions.
Eps soared by 64.54 % to $2.32 per share from $1.41 in the previous fiscal year, while Sales increased by 0.18 % from $781.93 millions a year ago.
CTRN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Teardroppers Inc
Teardroppers Inc announced earnings per share of $-0.00 and Sales of $0.02 millions in the fiscal period ending Dec 31 2020, Company's reached break-even per share, versus $-0.00 eps, earned in the same quarter a year ago, although Teardroppers Inc saw its Sales rise by 50.85% in the same period.
In contrast to the third quarter Sales increased by 3.89 % from $0.02 millions and from $0.00 per share.
In the fiscal year 2020, Citi Trends Inc reported Sales of $783.29 millions and net income of $23.98 millions.
Eps soared by 64.54 % to $2.32 per share from $1.41 in the previous fiscal year, while Sales increased by 0.18 % from $781.93 millions a year ago.
TRDP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Genethera Inc
In the fiscal time frame ending Dec 31 2020 Genethera Inc reached break-even of $-0.00 per share compared to $-0.01 a year ago and from $-0.01 per share from the previous quarter.
Genethera Inc reported operating deficit of $-0.132123 millions, in the fiscal time frame ending Dec 31 2020, an improvement from the operating loss of $-0.239101 millions, realized in fourth quarter of 2019
Genethera Inc reported net loss of $-0.77 millions and Sales of $0.00 millions for the fiscal year 2020.
Net loss per share has widen to $-0.04 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
GTHR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
High Sierra Technologies Inc
In the fourth quarter of 2020 High Sierra Technologies Inc increased losses of $-0.01 per share compared to $-0.00 a year ago and from $0.00 per share from the previous quarter.
High Sierra Technologies Inc reported operating shortfall of $-0.187955 millions, in the fourth quarter of 2020, a deterioration from the operating income of $0.012858 millions, realized in fourth quarter of 2019
Genethera Inc reported net loss of $-0.77 millions and Sales of $0.00 millions for the fiscal year 2020.
Net loss per share has widen to $-0.04 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
GLFO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![HK_CWB_World_Trade_Centre_office_lift_By_MARCO_LUOMEN_(Own-work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/realestate/HK_CWB_World_Trade_Centre_office_lift_By_MARCO_LUOMEN_(Own-work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "HK_CWB_World_Trade_Centre_office_lift_By_MARCO_LUOMEN_(Own-work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Eaco Corp
Eaco Corp realized a deterioration in earnings per share by -47.17% to $0.28 and Sales decrease by -1.9% to $55.75 millions in the most recent fiscal period, year on year.
From the preceding quarter, eps soared from $0.17 per share and Sales increased by 4.4 % from $53.40 millions.
EACO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Cannapharmarx Inc
Company reports $-11.55 million loss, as impairment charges strip off $6.03 million from the fourth quarter of 2020 earnings season results.
Cannapharmarx Inc reported operating deficit of $-9.815889 millions, in the fourth quarter of 2020 earnings season, a deterioration from the operating loss of $-7.985159 millions, realized in fourth quarter of 2019
Cannapharmarx Inc reported net loss of $-19.89 millions and Sales of $0.00 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.49 from $-0.66 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
CPMD stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
